Particle.news
Download on the App Store

Leap Therapeutics Becomes Cypherpunk, Deploys $50 Million Into Zcash Treasury

Backed by a Winklevoss-led $58.88 million raise, the Nasdaq company plans to keep accumulating ZEC toward a 5% supply target.

Overview

  • Cypherpunk disclosed the purchase of 203,775.27 ZEC using $50 million at an average price of about $245 per token, representing roughly 1.25% of the circulating supply.
  • Shares began trading under the new ticker CYPH on Nov. 13 as the firm pivoted from oncology R&D to a public digital-asset treasury focused on Zcash.
  • Khing Oei was appointed chairman and Winklevoss Capital principal Will McEvoy joined as chief investment officer and a director to steer the treasury strategy.
  • Company statements and an SEC filing outline an intention to hold at least 5% of Zcash’s supply and to participate in the Zcash community, while governance structures mean token ownership does not confer protocol control.
  • ZEC rallied sharply in recent weeks and the stock saw triple‑digit gains after the announcement, leaving Cypherpunk’s holdings with large unrealized gains at recent prices alongside heightened volatility.